Jaime Merchan, MD, is a professor, co-leader of the Translational and Clinical Oncology Research Program, and director of the Phase 1 Clinical Trials Program at the Sylvester Comprehensive Cancer Center at the University of Miami.
Merchan’s Takeaways From the CLEAR Study in Advanced RCC
Jaime Merchan, MD, discusses what the potential clinical implications or takeaways for colleagues are based on findings from the phase 3 CLEAR study in advanced renal cell carcinoma (RCC).
CLEAR Study Biomarker Analysis: Lenvatinib/Pembrolizumab vs Sunitinib Advanced Kidney Cancer
Jaime Merchan, MD, discusses findings from an analysis presented at the 2024 ASCO Meeting.